Cargando…
Targeting TM4SF1 exhibits therapeutic potential via inhibition of cancer stem cells
Autores principales: | Chen, Guang, She, Xiaofei, Yin, Yanxin, Ma, Junxian, Gao, Yaqun, Gao, Hua, Qin, Huanlong, Fang, Jianmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561108/ https://www.ncbi.nlm.nih.gov/pubmed/36229443 http://dx.doi.org/10.1038/s41392-022-01177-7 |
Ejemplares similares
-
Myeloid TM6SF2 Deficiency Inhibits Atherosclerosis
por: Zhu, Wenzhen, et al.
Publicado: (2022) -
Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance
por: Rahim, Nur Syafiqah, et al.
Publicado: (2023) -
Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma
por: Chen, Zhouxun, et al.
Publicado: (2011) -
Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells
por: Park, Sangkyu, et al.
Publicado: (2020) -
LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2
por: Li, Qian, et al.
Publicado: (2019)